the IP and technology aspects of complex corporate transactions, including mergers and acquisitions, divestitures, spin-offs, carve-outs, financings and investments;
the structuring and negotiation of complex, standalone IP transactions, including strategic alliances and joint ventures and collaboration and development, license, services and distribution agreements.

Marisa also provides broad-based counseling services covering IP matters and advises on the settlement of IP disputes. She represents clients in a diversity of industries, including internet, social and digital media, software, hardware, emerging technologies, pharmaceuticals, biotechnology, healthcare services, retail, e-commerce, manufacturing, and consumer products, among others.

Marisa has been recognized among leading lawyers advising on intellectual property and technology transactions by Chambers USA and Legal 500 USA. Legal 500 USA named Marisa for Technology Transactions (USA) in each of 2024 and 2025 and recommended Marisa for Patents: Licensing and IT & Outsourcing: Transactions (NY) in 2021. In 2019, Chambers USA named Marisa as the only “Associate to Watch” in IT & Outsourcing: Transactions (NY).

Experience

Marisa’s experience on publicly reported matters includes:

Internet and Digital Media

Facebook (now Meta Platforms) in its $19 billion acquisition of WhatsApp
Yahoo! in its:
- $4.5 billion acquisition by Verizon Communications
- divestiture of an 80% stake in its e-commerce business in Taiwan to Uni-President Enterprises Corp.
- strategic acquisitions of, or asset acquisitions from, 18 software, media and technology companies
- 30-year exclusive agreement with Taboola for native advertising on Yahoo’s digital properties
- sale to Yahoo Japan Corporation of rights to the Yahoo brand in Japan and global rights to the Yahoo Japan brand, along with a perpetual license to specified Yahoo technology, for $1.6 billion
- sale of Edgecast to Limelight Networks

Software and Technology, including Artificial Intelligence and Emerging Technologies

Aptiv in its $4.3 billion acquisition of Wind River from TPG Capital
Blue Yonder in its acquisition of One Network Enterprises for approximately $839 million
Centerbridge Partners as lead investor in a $700 million private financing of Sabre Corporation
KKR in its approximately $4 billion acquisition of Broadcom’s End-User computing division
Softbank Vision Fund in its:
- $2.25 billion minority investment in GM Cruise Holdings (Cruise) alongside a $1.1 billion investment in Cruise by GM
- $1 billion investment in the Advanced Technologies Group of Uber Technologies
- $500 million minority investment in Cambridge Mobile Telematics
Sensor Tower in its acquisition of Data.ai
Twilio in its acquisition of Authy
Qualcomm in its $4.5 billion topping bid for Veoneer

Chemicals, Manufacturing, Energy and Transportation

AGCO in its:
- joint venture with Trimble to acquire an 85% interest in Trimble’s portfolio of agriculture assets and technologies for $2 billion in cash
- agreement to sell the majority of its Grain & Protein business to American Industrial Partners for $700 million in cash
Apollo Global Management in its all-cash, take-private acquisition of Arconic Corporation
Carrier Global Corporation in its approximately €12 billion acquisition of Viessmann Climate Solutions.
Clariant AG in its $810 million cash acquisition of Lucas Meyer Cosmetics from International Flavors & Fragrances
EQT Partners in its acquisition of Lazer Logistics, North America’s largest provider of outsourced yard management and trailer spotting services
General Electric in the spin-offs of GE Healthcare and GE Vernova and the launch of GE Aerospace
Mosaic in its agreement to sell its 25% stake in a Saudi Arabian Phosphate joint venture to Saudi Arabian Mining Company

Pharmaceuticals and Biotechnology

Covis Pharma Group in its $270 million acquisition of global rights to two respiratory therapies, Eklira and Duaklir, from AstraZeneca
CSL Behring in its up to $416 million acquisition of Calimmune
Eli Lilly and Company in:
- its $1 billion acquisition of Prevail Therapeutics
- its global exclusive licensing and research collaboration with, and equity investment in, Precision Biosciences
- its collaboration and licensing agreements with each of AbCellera Biologics and Junshi Biosciences to develop monoclonal antibody therapies for COVID-19, as well as its supply arrangements for such therapies with the U.S. Government
- the restructuring of its worldwide alliance with Boehringer Ingelheim
GlaxoSmithKline in its $2 billion acquisition of BELLUS Health
Halozyme Therapeutics in its global collaboration and license agreement with ViiV Healthcare
Merz North America in its:
- $600 million acquisition of Ulthera
- acquisition of On Light Sciences
Progeria Research Foundation in its collaboration and supply arrangement with Eiger Bio Pharmaceuticals
SOLVE FSHD in its strategic collaboration with Transcripta Bio to advance drug discovery for facioscapulohumeral muscular dystrophy (FSHD)

Healthcare Services and Diagnostics

Amedisys in its $3.3 billion merger with Optum
Health Management Associates in its $7.6 billion sale to Community Health Systems
Quest Diagnostics in its:
- strategic partnership and preferred supply arrangement for immunoassay testing with Siemens Healthineers
- acquisition of the U.S. laboratory services business of Oxford Immunotec Global, along with an associated long term supply arrangement
- acquisition of Blueprint Genetics

Financial Services

Mizuho Financial Group in its acquisition of Greenhill & Co.
A consortium of institutional investors led by Sixth Street in their acquisition of the GreenSky lending and servicing platform and associated loan assets from Goldman Sachs

Marisa completed a secondment under the head of the IP Transaction Group at Yahoo! in 2014 and served as a voting member on the IP Licensing Standards Committee of the Licensing Executives Society of USA and Canada from 2020-2021.

Marisa B.Geiger

Marisa B.
Geiger